Objectives The newly revised Rome criteria for the definition of irritable bowel syndrome (IBS), derived from the consensus of experts in the field, were developed in order to identify subgroups of IBS patients for research. The criteria have, to our knowledge, never been validated. Both when trying to include IBS patients in studies and in clinical practice we found it difficult to apply the Rome 2 supportive criteria.
Introduction
Irritable bowel syndrome (IBS) is a condition characterised by a constellation of symptoms, rather than a discrete clinical entity defined by one or more precise, measurable, 'organic' abnormalities [1] . Subgroups of patients with IBS are likely to respond differently to existing and evolving therapies [2] . As there is no consensus on the pathophysiological basis of IBS, inclusion criteria and trial outcomes for clinical studies are dependent on symptom reports. Traditionally, IBS has been divided into diarrhoea-and constipationpredominant. Recent consensus (Rome 2) has proposed that patients with diarrhoea-predominant IBS should have more than three bowel movements a day, or loose stools or urgency, while patients with constipation-predominant IBS should have fewer than three bowel movements a week, or hard or lumpy stools or straining during a bowel movement [3] . Moreover, patients belonging to one subgroup should not have any of the items present in the other subgroup (Table 1) .
Our clinical impression from trials is that almost all patients with IBS have some proportion of all defecatory symptoms, and even stool frequency seems to be independent of stool consistency.
Our aim was to study the variation of stool consistency and defecatory symptoms in IBS patients with diary cards to validate the Rome 2 supportive criteria and to identify stool-consistency subgroups.
Materials and methods
Patients were included consecutively according to the Rome 1 criteria and the absence of organic disease, as described earlier [4] . The patients were referred by primary-care physicians to our unit, the department of gastroenterology. Each patient underwent an extensive interview and a thorough physical examination. Using a questionnaire, the patients were asked about gastrointestinal symptoms. Blood samples were taken from all patients for analysis of haemoglobin, leucocytes, platelets, alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), electrolytes, albumin, blood glucose, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Urine was tested for protein, glucose, and red and white blood cells, and faeces were tested for occult blood. Rigid sigmoidoscopy was performed in all patients. When indicated by medical history, the following tests were performed: thyroid function, upper endoscopy, smallbowel biopsy, abdominal ultrasound, lactose-intolerance test, xylose breath test, assessment of bile-acid malabsorption, stool culture, barium enema and/or colonoscopy. The results of all tests were normal. All patients were seen or contacted during a follow-up period of at least 2 years to ascertain that no organic disease had been diagnosed subsequently.
Sixty IBS patients (22 men) kept daily records of their abdominal symptoms over 40 days (Fig. 1) . They recorded every stool, stool consistency, corresponding defecatory symptoms (urge, straining, feeling of incomplete evacuation) and episodes of pain and bloating. As presented in the diary cards ( Fig. 1 ), patients were asked to define stool consistency as 'loose', 'normal', 'hard' or 'very hard' stool, with separate hard lumps like nuts' for every bowel movement. Based on stool consistency, subgroups were defined, and associations with other symptoms were investigated. Patients were also classified into subgroups according to the Rome 2 supportive criteria.
Data were expressed in median values and percentiles, mean values and standard 95% confidence intervals (CI). To compare groups, the Kruskall-Wallis test and the Mann-Whitney U test were used. P values of less than 0.05 were considered significant.
Ethics
This study was approved by the Committee of Research Ethics at the Faculty of Health Sciences, University of Linkö ping, Sweden. Patients gave oral informed consent to participate in the study.
Results
Using the Rome 2 criteria, we could define seven (12%) patients as having diarrhoea-predominant IBS, based on the presence of loose stools and urge, and the absence of straining and hard stools. We could not classify any patient as constipation-predominant IBS, as urge was present in all but three patients, who, however, had some degree of loose stools.
Based on stool consistency, four main subgroups were identified ( Table 2 ). The largest subgroup (n ¼ 25)
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had alternating bowel habits, with at least 10.0% (median 29.0%) loose stools and at least 10.0% (median 25%) hard stools. The second largest subgroup (n ¼ 19) was the loose-stool-predominant group, with median 52.0% loose stools, 48.0% normal stools and 2.0% hard stools. One subgroup (n ¼ 6) was hard-stoolpredominant, with median 25.5% hard stools, 69.5% normal stools and 5.0% loose stools. One group (n ¼ 7) had more than 97.0% loose stools. One patient had 90.0% hard stools, and two patients had more than 93.5% normal stools. Although some association between subgroups and defecatory symptoms was found (Fig. 2) , urgency, straining and feeling of incomplete evacuation occurred independently of stool consistency in 53 of 60 (88%) individuals. The alternating subgroup had a feeling of incomplete evacuation more often than the loose-stool-predominant subgroup (P , 0.01), and had more urge (P , 0.01) and less straining (P , 0.05) than the hard-stool-predominant subgroup. The hard-stool-predominant subgroup had more straining episodes than the loose-stool-predominant subgroup (P , 0.01).
All patients suffered either pain (two patients) or bloating (four patients), or both (54 patients). They had 178 (mean; 95% CI 120.4-235.5) hours of pain, 29.9 (mean; 95% CI 24.1-35.7) episodes of pain, and 22.9 (mean; 95% CI 18.6-27.1) episodes of bloating. According to pain, bloating and number of stools, there was no difference between the subgroups. Pain was worsened or initiated by the intake of a meal, as described elsewhere [4] .
Discussion
Our main finding was that IBS patients had straining even with loose stools and urgency even with hard
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Although this study showed that there is some relation between stool consistency and defecatory symptoms, the presence or absence of a certain defecatory symptom could not be used to subclassify IBS into diarrhoea-and constipation-predominant, as suggested by the Rome 2 criteria. Moreover, our study shows that stool frequency was not significantly different between the stool consistency groups (Table 2 ) and therefore cannot be used to define subgroups.
The division of IBS patients into diarrhoea-and constipation-predominant, based on questionnaires, as is customary in clinical trials, is very imprecise and probably leads to unreliable study results. Retrospective ratings of symptoms with questionnaires are also subjected to the bias of recall [6] .
We suggest that the Rome 2 supportive criteria have to be reconsidered, as the determination of the presence or absence of specific symptoms does not work as an instrument for categorisation of IBS patients into diarrhoea-and constipation-predominant. We propose that IBS patients with alternating bowel habits should form a subgroup on their own, not being forced into either the constipation-or the diarrhoea-predominant subgroup. We suggest that IBS subgroups should be based on either stool consistency or defecatory symptoms, but not both. Based on the heterogeneity of the syndrome and on the difficulties of recall, the use of diary cards for prospective symptom recording should be a mandatory part in clinical studies.
